Fetal rejection: infertility and immunity

References

• Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol.7, 320–338 (1953).
   Google Scholar
• Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia – the same basic mechanism? Hum. Immunol.67(7), 492–511 (2006).
   PubMed Web of Science ®Google Scholar
• Mills JL, Simpson JL, Driscoll SG et al. Evidence of spontaneous abortion among normal women and insulin-dependent women whose pregnancies were identified within 21 days of conception. N. Engl. J. Med.319, 1617–1623 (1988).
   PubMed Web of Science ®Google Scholar
• Staray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol.148, 140–146 (1984).
   PubMedGoogle Scholar
• Porter TF. Evidence-based care of recurrent miscarriage. Best Pract. Res. Clin. Obstet. Gynaecol.19, 85–101 (2005).
   PubMedGoogle Scholar
• Clark DA, Coulam CB, Daya S, Chaouat G. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum. Reprod. Update7, 501–511 (2001).
   PubMed Web of Science ®Google Scholar
• Coulam CB, McIntyre JA, Faulk WP. Reproductive performance in women with repeated pregnancy losses and multiple partners. Am. J. Reprod. Immunol. Microbiol.12, 10–12 (1976).
   Google Scholar
• Carp HJA, Toder V, Torchinsky A et al.; Recurrent Miscarriage Immunotherapy Trialist Group. Allogenic leukocyte immunization after five or more miscarriages. Hum. Reprod.12, 250–255 (1997).
   PubMed Web of Science ®Google Scholar
• McIntyre JA, McConnachie PR, Taylor CG, Faulk WP. Clinical, immunologic and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertil. Steril.42, 849–852 (1984).
   PubMedGoogle Scholar
• Coulam CB. Immunologic tests in the evaluation of reproductive disorders: a critical review. Am. J. Obstet. Gynecol.167, 1844–1851 (1992).
   PubMedGoogle Scholar
• Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD. Systemic CD56+ cells can predict pregnancy outcome. Am. J. Reprod. Immunol.33, 40–46 (1995).
   PubMedGoogle Scholar
• De Boer P, van der Hoeven FA, Wolters EMTJ et al. Embryo loss, blastomere development and chromosome constitution after human chorionic gonadotropin-induced ovulation in mice and rats with regular cycles. Gynecol. Obstet. Invest.32, 200–205 (1991).
   PubMedGoogle Scholar
• Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBA×DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J. Immunol.160, 545–549 (1998).
   PubMed Web of Science ®Google Scholar
• Clark DA, Foerster K, Fung L et al. The fgl2 prothrombinase/fibroleukin gene is required for lipopolisaccharide-triggered abortions and for normal mouse reproduction. Mol. Hum. Reprod.10, 99–108 (2004).
   PubMed Web of Science ®Google Scholar
• Svensson L, Arvola M, Sällström MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J. Reprod. Immunol.51, 3–7 (2001).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion. Am. J. Pathol.166, 811–822 (2005).
   PubMed Web of Science ®Google Scholar
• Aluvihare V, Kallikourdis M, Betz A. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol.3, 266–271 (2004).
   Google Scholar
• Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature4, 762–774 (2004).
   Google Scholar
• Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol.61, 67–77 (2004).
   PubMed Web of Science ®Google Scholar
• Ryter SW, Otterbein LE, Morse D, Choi BM. Heme oxygenase/carbon monoxide signalling pathways: regulation and functional significance. Mol. Cell. Biochem.234, 249–263 (2002).
   PubMed Web of Science ®Google Scholar
• Ning W, Choi AM, Li C. Carbon monoxide inhibits IL-17-induced IL-6 production through the MAPK pathway in human pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.289, 268–273 (2005).
   Google Scholar
• Choi BM, Pae HO, Jeong YR, Kim YM, Chunk HT. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun.327, 1066–1071 (2005).
   PubMedGoogle Scholar
• Zenclussen AC, Fest S, Busse P, Joachim R, Klapp BF, Arck PC. Questioning the Th1/Th2 paradigm in reproduction: peripheral levels of IL-12 are down-regulated in miscarriage patients. Am. J. Reprod. Immunol.48, 245–251 (2002).
   PubMedGoogle Scholar
• Kingsley CI, Karim M, Bushell AR, Wood K. CD25+CD4+ regulatory T cells prevent graft rejection: cTLA4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol.168, 1080–1086 (2002).
   PubMed Web of Science ®Google Scholar
• Zenclussen ML, Anegon I, Bertoja ZA et al. Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J. Reprod. Immunol.69, 35–52 (2006).
   PubMedGoogle Scholar
• Sollwedel A, Bertoja AZ, Zenclussen ML et al. Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface. J. Immunol.175, 4875–4885 (2005).
   PubMedGoogle Scholar
• Saito S, Sasaki Y, Sakai M. CD4+CD25high regulatory T cells in human pregnancy. J. Reprod. Immunol.65, 111–120 (2005).
   PubMed Web of Science ®Google Scholar
• Ntrivalas EI, Kwak-Kim JYH, Gilman-Sachs A et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum. Reprod.16, 855–861 (2001).
   PubMed Web of Science ®Google Scholar
• Pandey MK, Thakur S, Agrawal S. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch. Gynecol. Obstet.269, 161–172 (2004).
   PubMedGoogle Scholar
• Marzi M, Vigano A, Trabattoni D et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol.106, 127–133 (1996).
   PubMed Web of Science ®Google Scholar
• Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med.4, 1020–1024 (1998).
   PubMed Web of Science ®Google Scholar
• Makhseed M, Ragupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum. Reprod.16, 2219–2226 (2001).
   PubMed Web of Science ®Google Scholar
• Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am. J. Reprod. Immunol.54, 203–216 (2005).
   PubMedGoogle Scholar
• Zenclussen AC, Lim E, Knoeller S, Knackstedt M et al. Heme oxygenases in pregnancy II: HO-2 is downregulated in human pathologic pregnancies. Am. J. Reprod. Immunol.50, 66–76 (2003).
   PubMed Web of Science ®Google Scholar
• Miwa N, Hayakawa S, Miyazaki S et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-γ increase in normal pregnancy but decrease in spontaneous abortion. Mol. Hum. Reprod.11, 865–870 (2005).
   PubMed Web of Science ®Google Scholar
• Clark DA, Chaouat G. Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am. J. Reprod. Immunol.53, 13–20 (2005).
   PubMedGoogle Scholar
• Chaouat G, Lankar D. Vaccination against spontaneous abortion in mice by preimmunization with an anti-idiotypic antibody. Am. J. Reprod. Immunol.16, 146–150 (1988).
   Google Scholar
• Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliott JF, Mosmann T. IL-10 prevents naturally occurring fetal loss in the CBA×DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J. Immunol.154, 4261–4268 (1995).
   PubMed Web of Science ®Google Scholar
• Blois S, Tometten M, Kandil J et al. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J. Immunol.174, 1820–1829 (2005).
   PubMedGoogle Scholar
• Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor. J. Exp. Med.194, 629–644 (2001).
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med.190, 995–1004 (1999).
   PubMed Web of Science ®Google Scholar
• Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med.192, 295–302 (2000).
   PubMed Web of Science ®Google Scholar
• Clark DA. Hard science versus phenomenology in reproductive immunology. Crit. Rev. Immunol.19, 509–539 (1999).
   PubMedGoogle Scholar
• Christiansen OB, Nielsen HS, Pedersen B. Active or passive immunization in unexplained recurrent miscarriage. J. Reprod. Immunol.62, 41–52 (2004).
   PubMedGoogle Scholar
• Behar E, Carp H, Livneh A, Gazit E. Differential suppression activity induced by paternal leukocyte immunization in habitual abortion. Gynecol. Obstet. Invest.36, 202–207 (1993).
   PubMedGoogle Scholar
• Hayakawa S, Karasaki-Suzuki M, Itoh T et al. Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR V β and V γ repertoire usage of patients with recurrent spontaneous abortions. Am. J. Reprod. Immunol.43, 107–115 (2000).
   PubMed Web of Science ®Google Scholar
• Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE. Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am. J. Reprod. Immunol.34, 352–358 (1998).
   Google Scholar
• Margni RA, Zenclussen AC. During pregnancy, in the context of a Th2-type cytokine profile, serum IL-6 levels might condition the quality of the synthesised antibodies. Am. J. Reprod. Immunol.46, 181–187 (2001).
   PubMedGoogle Scholar
• Zenclussen AC, Gentile T, Kortebani G, Mazzoli A, Margni R. Asymmetric antibodies and pregnancy. Am. J. Reprod. Immunol.45, 289–294 (2001).
   PubMedGoogle Scholar
• Pereira A, Vamvakas EC, Blajchman MA. Deletorious consequences of allogeneic blood transfusion on postoperative infection: really a transfusion-related immunomodulation effect? Blood98, 498–500 (2001).
   PubMedGoogle Scholar
• Daya S, Gunby J. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am. J. Reprod. Immunol.32, 294–302 (1994).
   Google Scholar
• Ober C, Karrison T, Odem RR et al. Mononuclear-cell immunisation in the prevention of recurrent miscarriages: a randomised trial. Lancet354, 365–369 (1999).
   PubMed Web of Science ®Google Scholar
• Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev.1, CD000112 (2003).
   Google Scholar
• Chaouat G. Should we re-examine the status of lymphocyte alloimmunization therapy for recurrent spontaneous abortion? Am. J. Reprod. Immunol.50, 433–438 (2003).
   PubMedGoogle Scholar
• Clark DA. Shall we properly re-examine the status of allogeneic lymphocyte therapy for recurrent early pregnancy failure? Am. J. Reprod. Immunol.51, 7–15 (2004).
   Google Scholar
• Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol.31, 81–95 (1996).
   PubMed Web of Science ®Google Scholar
• Blois SM, Joachim R, Kandil J et al. Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile 1. J. Immunol.172, 5893–5899 (2004).
   PubMed Web of Science ®Google Scholar
• Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Br. J. Obstet. Gynecol.112, 1096–1101 (2005).
   Google Scholar
• Gruber CJ, Huber JC. The role of dydrogesterone in recurrent (habitual) abortion. J. Steroid Biochem. Mol. Biol.97, 426–430 (2005).
   PubMed Web of Science ®Google Scholar
• Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst. Rev.4, CD003511 (2003).
   Google Scholar
• Tempfer CB, Kurz C, Bentz EK et al. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil. Steril.86, 145–148 (2006).
   PubMed Web of Science ®Google Scholar
• Christiansen OB. A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum. Reprod. Update2, 271–293 (1996).
   PubMed Web of Science ®Google Scholar
• Lorenz A, Blasczyk R, Kuhn U, Venjakob U, Mendonca M, Grosse-Wilde H. Strong association between the responder status of the FcγR-II receptor and recurrent spontaneous abortion. Eur. J. Immunogenet.22, 397–401 (1995).
   PubMedGoogle Scholar
• Jalali GR, Arck P, Surridge S et al. Immunosuppressive properties of monoclonal antibodies and human polyclonal alloantibodies to the R80K protein of trophoblast. Am. J. Reprod. Immunol.36, 129–134 (1996).
   PubMedGoogle Scholar
• Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens60, 122–132 (2002).
   PubMed Web of Science ®Google Scholar
• Loke YW, King A. Evolution of the fetal–maternal immunological relationship. Am. J. Reprod. Immunol.35, 256–257 (1996).
   PubMedGoogle Scholar
• Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum. Reprod.17, 2439–2444 (2002).
   PubMed Web of Science ®Google Scholar
• Daher S, Shulzhenko N, Morgun A et al. Association between cytokine gene polymorphisms and recurrent pregnancy loss. J. Reprod. Immunol.58, 69–77 (2003).
   PubMed Web of Science ®Google Scholar
• Kwak-Kim JY, Chung-Bang HS, Ng SC et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum. Reprod.18, 767–773 (2003).
   PubMed Web of Science ®Google Scholar
• Hamai Y, Fujii T, Yamashita T et al. Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells. Am. J. Reprod. Immunol.40, 408–413 (1998).
   PubMedGoogle Scholar
• Schweikert A, Rau T, Berkholz A, Allera A, Daufeldt S, Wildt L. Association of progesterone receptor polymorphism with recurrent abortions. Eur. J. Obstet. Gynecol. Reprod. Biol.113, 67–72 (2004).
   PubMedGoogle Scholar
• Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D et al. Natural killer (NK) cell receptors’ repertoire in couples with recurrent spontaneous abortions. Am. J. Reprod. Immunol.49, 183–191 (2003).
   PubMed Web of Science ®Google Scholar
• Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am. J. Reprod. Immunol.52, 36–41 (2004).
   PubMed Web of Science ®Google Scholar
• Zammiti W, Mtiraoui N, Cochery-Nouvellon E, Mahjoub T, Almawi WY, Gris JC. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod.12, 771–776 (2006).
   PubMed Web of Science ®Google Scholar
• Wang ZC, Yunis EJ, De los Santos MJ, Xiao L, Anderson DJ, Hill JA. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun.3, 38–42 (2002).
   PubMed Web of Science ®Google Scholar
• Denschlag D, Marculescu R, Unfried G et al. The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol. Hum. Reprod.10, 211–214 (2004).
   PubMedGoogle Scholar
• Stern C, Pertile M, Norris H, Hale L, Baker HW. Chromosome translocations in couples with in vitro fertilization implantation failure. Hum. Reprod.14, 2097–2101 (1999).
   PubMed Web of Science ®Google Scholar
• Kahraman S, Yakin K, Samli M et al. A comparative study of three techniques for the analysis of sperm recovery: touch-print cytology, wet preparation and testicular histopathology. J. Assist. Reprod. Genet.18, 357–363 (2001).
   PubMedGoogle Scholar
• Bao L, Devi S, Bowen-Shauver J, Ferguson-Gottschall S, Robb L, Gibori G. The role of intrleukin-11 in pregnancy involves up-regulation of α2-macroglobulin gene through janus kinase 2-signal transducer and activator of transcription 3 pathway in the decidua. Mol. Endocrinol.20, 3240–3250 (2006).
   PubMed Web of Science ®Google Scholar
• Lim KJH, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID. Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol. Hum. Reprod.4, 77–81 (1998).
   PubMedGoogle Scholar
• Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J. Reprod. Immunol.52, 35–43 (2001).
   PubMed Web of Science ®Google Scholar
• Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN. Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am. J. Reprod. Immunol.46, 386–392 (2001).
   PubMed Web of Science ®Google Scholar
• Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod.12, 301–308 (2006).
   PubMed Web of Science ®Google Scholar
• Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum. Reprod.17, 213–218 (2002).
   PubMed Web of Science ®Google Scholar
• Ledee-Bataille N, Olivennes F, Kadoch J et al. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Hum. Reprod.19, 1968–1973 (2004).
   PubMed Web of Science ®Google Scholar
• Coulam CB, Roussev RG. Increasing circulating T-cell activation markers are linked to subsequent implantation failure after transfer of in vitro fertilized embryos. Am. J. Reprod. Immunol.50, 340–345 (2003).
   PubMedGoogle Scholar
• Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am. J. Reprod. Immunol.48, 77–86 (2002).
   PubMed Web of Science ®Google Scholar
• Beer AE, Kwak JY, Ruiz JE. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am. J. Reprod. Immunol.35, 376–82 (1996).
   PubMed Web of Science ®Google Scholar
• Thum MY, Bhaskaran S, Bansal AS et al. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum. Reprod.20, 1272–1276 (2005).
   PubMed Web of Science ®Google Scholar
• Ntrivalas EI, Bowser CR, Kwak-Kim J, Beaman KD, Gilman-Sachs A. Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures. Am. J. Reprod. Immunol.53, 215–221 (2005).
   PubMed Web of Science ®Google Scholar
• Inagaki N, Stern C, McBain J, Lopata A, Kornman L, Wilkinson D. Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum. Reprod.18, 608–615 (2003).
   PubMed Web of Science ®Google Scholar
• Ashkar A, Di Santo J, Croy A. Interferon-γ contributes to initiation of uterine vascular modification, decidual integrity and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med.192, 259–270 (2000).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? Immunol. Lett.92, 207–214 (2004).
   PubMed Web of Science ®Google Scholar
• Croy BA, Esadeg S, Chantakru S et al. Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J. Reprod. Immunol.59, 175–191 (2003).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Zourbas S et al. Implantation: can immunological parameters of implantation failure be of interest for pre-eclampsia? J. Reprod. Immunol.59, 205–217 (2003).
   PubMed Web of Science ®Google Scholar
• Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with history of repeated in vitro fertilization-embryo transfer failure. Fertil. Steril.83, 598–605 (2005).
   PubMed Web of Science ®Google Scholar
• Ledee-Bataille N, Dubanchet S, Coulomb-L’hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil. Steril.81, 59–65 (2004).
   PubMed Web of Science ®Google Scholar
• Steck T. Immunotherapy for prevention of abortion and for improving implantation in extracorporeal fertilization. Zentralbl. Gynakol.123, 357–360 (2001).
   PubMedGoogle Scholar
• Steck T, Giess R, Suetterlin MW et al. Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur. J. Obstet. Gynecol. Reprod. Biol.112, 69–73 (2004).
   PubMed Web of Science ®Google Scholar
• Maes M, Song C, Lin A et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine10, 313–318 (1998).
   PubMed Web of Science ®Google Scholar
• Gallinelli A, Roncaglia R, Matteo ML, Ciaccio I, Volpe A, Facchinetti F. Immunological changes and stress are associated with different implantation rates in patients undergoing in vitro fertilization-embryo transfer. Fertil. Steril.76, 85–91 (2001).
   PubMed Web of Science ®Google Scholar
• Spandorfer SD, Neuer A, Giraldo PC, Rosenwaks Z, Witkin SS. Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J. Reprod. Med.46, 806–810, (2001).
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost.4, 295–306 (2006).
   PubMed Web of Science ®Google Scholar
• Berman J, Girardi G, Salmon JE. TNF-α is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J. Immunol.174, 485–490 (2005).
   PubMed Web of Science ®Google Scholar
• Girardi G, Berman J, Redecha P et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest.112, 1644–1654 (2003).
   PubMed Web of Science ®Google Scholar
• Gharavi AE, Pierangeli SS, Levy RA, Harris EN. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin. Obstet. Gynecol.44, 11–19 (2001).
   PubMed Web of Science ®Google Scholar
• McIntyre JA. Antiphospholipid antibodies in implantation failures. Am. J. Reprod. Immunol.49, 221–229 (2003).
   PubMedGoogle Scholar
• Coulam CB, McIntyre JR, Wagenknecht D, Rote N. Inter-laboratory inconsistencies in detection of anticardiolipin antibodies. Lancet335, 865 (1990).
   PubMed Web of Science ®Google Scholar
• Tincani A, Allegri F, Sanmarco M et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost.86, 575–583 (2001).
   PubMed Web of Science ®Google Scholar
• Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome. A systematic review. JAMA295, 1050–1057 (2006).
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126, 627S–644S (2004).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Autoantibodies and infertility: current opinion. Hum. Reprod. Update4, 169–176 (1998).
   PubMedGoogle Scholar
• Singh A, Dantas ZN, Stone SS, Asch RH. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil. Steril.63, 277–281 (1995).
   PubMed Web of Science ®Google Scholar
• Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil. Steril.76, 694–699 (2001).
   PubMedGoogle Scholar
• Matsubayashi H, Sugi T, Arai T et al. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am. J. Reprod. Immunol.46, 323–329 (2001).
   PubMedGoogle Scholar
• Cubillos J, Lucena A, Lucena C et al. Incidence of autoantibodies in the infertile population. Early Pregnancy3, 119–124 (1997).
   PubMedGoogle Scholar
• Kaider AS, Kaider BD, Janowicz PB, Roussev RG. Immunodiagnostic evaluation in women with reproductive failure. Am. J. Reprod. Immunol.42, 335–346 (1999).
   PubMed Web of Science ®Google Scholar
• Stewart-Akers AM, Krasnow JS, Brekosky J, DeLoia JA. Endometrial leukocytes are altered numerically and functionally in women with implantation defects. Am. J. Reprod. Immunol.39, 1–11 (1998).
   PubMed Web of Science ®Google Scholar
• Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum. Reprod.15, 1637–1639 (2000).
   PubMed Web of Science ®Google Scholar
• Mattila K, Vaarala O, Palosuo T et al. Serological response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clin. Immunol. Immunopathol.51, 414–418 (1989).
   PubMedGoogle Scholar
• Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today14, 203-208 (1993).
   PubMedGoogle Scholar
• Nelson JL. Microchimerism and autoimmune disease. N. Engl. J. Med.338, 1224–1225 (1998).
   PubMed Web of Science ®Google Scholar
• Many A, Pauzner R, Carp H, Langevitz P, Martinovitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am. J. Reprod. Immunol.28, 216–218 (1992).
   PubMed Web of Science ®Google Scholar
• Sher G, Zouves C, Feinman M et al. A rational basis for the use of heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am. J. Reprod. Immunol.39, 391–394 (1998).
   PubMed Web of Science ®Google Scholar
• Zheng Y, Manzotti CM, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol.172, 2778–2784 (2004).
   PubMed Web of Science ®Google Scholar
• Sansom DM, Walker LSK. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev.212, 131–148 (2006).
   PubMed Web of Science ®Google Scholar
• Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function. Eur. J. Immunol.34, 2996–3005 (2004).
   PubMed Web of Science ®Google Scholar
• Lewkowicz P, Lewkowicz N, Sasiak A, Tchorzewski H. Lipopolisaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol.177, 7155–7163 (2006).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol.22, 531–562 (2004).
   PubMed Web of Science ®Google Scholar
• Yao M, Lim W, Schust DJ et al. Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Mol. Endocrinol.17, 610–627 (2003).
   PubMedGoogle Scholar
• Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolisaccharide-induced abortion and fetal growth restriction in mice. Biol. Reprod.76, 738–748 (2007).
   PubMed Web of Science ®Google Scholar